Joyce H. S. You

3.8k total citations
121 papers, 2.7k citations indexed

About

Joyce H. S. You is a scholar working on Epidemiology, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joyce H. S. You has authored 121 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 27 papers in Economics and Econometrics and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joyce H. S. You's work include Health Systems, Economic Evaluations, Quality of Life (23 papers), Influenza Virus Research Studies (12 papers) and Pharmaceutical Economics and Policy (11 papers). Joyce H. S. You is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (23 papers), Influenza Virus Research Studies (12 papers) and Pharmaceutical Economics and Policy (11 papers). Joyce H. S. You collaborates with scholars based in Hong Kong, China and United States. Joyce H. S. You's co-authors include Gregory Cheng, Wai‐Kit Ming, Xinchan Jiang, Raymond Wong, Minghuan Jiang, Francis K.L. Chan, Joseph J.�Y. Sung, Enders K. Ng, Kenneth K.C. Lee and Margaret Ip and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Joyce H. S. You

112 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joyce H. S. You Hong Kong 26 598 526 489 475 407 121 2.7k
Brian L. Erstad United States 37 863 1.4× 158 0.3× 523 1.1× 558 1.2× 159 0.4× 279 5.1k
Mariam Molokhia United Kingdom 30 380 0.6× 67 0.1× 733 1.5× 556 1.2× 729 1.8× 89 3.8k
Robert MacLaren United States 35 561 0.9× 180 0.3× 668 1.4× 397 0.8× 155 0.4× 140 3.7k
Joseph T. DiPiro United States 32 913 1.5× 74 0.1× 677 1.4× 327 0.7× 114 0.3× 180 3.7k
Susan E. Tett Australia 37 948 1.6× 83 0.2× 523 1.1× 144 0.3× 421 1.0× 119 5.4k
Évelyne Jacqz-Aigrain France 44 621 1.0× 150 0.3× 1.2k 2.4× 141 0.3× 1.2k 3.1× 307 7.3k
Sarah Meredith United Kingdom 29 489 0.8× 69 0.1× 772 1.6× 454 1.0× 134 0.3× 65 4.1k
Lynda S. Welage United States 23 318 0.5× 286 0.5× 185 0.4× 86 0.2× 223 0.5× 72 1.8k
Annmarie Touborg Lassen Denmark 33 1.7k 2.9× 704 1.3× 903 1.8× 587 1.2× 28 0.1× 202 4.0k
Ying P. Tabak United States 28 1.1k 1.8× 326 0.6× 1.4k 2.9× 403 0.8× 19 0.0× 67 3.9k

Countries citing papers authored by Joyce H. S. You

Since Specialization
Citations

This map shows the geographic impact of Joyce H. S. You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce H. S. You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce H. S. You more than expected).

Fields of papers citing papers by Joyce H. S. You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce H. S. You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce H. S. You. The network helps show where Joyce H. S. You may publish in the future.

Co-authorship network of co-authors of Joyce H. S. You

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce H. S. You. A scholar is included among the top collaborators of Joyce H. S. You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce H. S. You. Joyce H. S. You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rui, Mingjun, Yingcheng Wang, & Joyce H. S. You. (2025). Health Economic Evaluations of Circulating Tumor DNA Testing for Cancer Screening: Systematic Review. Cancer Medicine. 14(3). e70641–e70641. 4 indexed citations
2.
Wang, Yingcheng, et al.. (2025). Cost-effectiveness of maternal vaccination against respiratory syncytial virus in Hong Kong: a decision-analytical analysis. Expert Review of Vaccines. 24(1). 1015–1023.
3.
You, Joyce H. S., et al.. (2023). Health economic analysis of epidermal growth factor receptor mutation-guided first-line therapies for advanced non-small-cell lung cancer: abridged secondary publication.. PubMed. 29 Suppl 2(1). 8–11. 1 indexed citations
4.
Fekadu, Ginenus, et al.. (2022). Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States. Scientific Reports. 12(1). 18349–18349. 1 indexed citations
5.
Jiang, Xinchan, et al.. (2021). Cost-effectiveness of a Telemonitoring Program for Patients With Heart Failure During the COVID-19 Pandemic in Hong Kong: Model Development and Data Analysis. Journal of Medical Internet Research. 23(3). e26516–e26516. 8 indexed citations
6.
Jiang, Xinchan, et al.. (2020). Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis. JMIR mhealth and uhealth. 8(7). e17846–e17846. 18 indexed citations
7.
Mak, Arthur D. P., Vincent CH Chung, Yee Kit Tse, et al.. (2019). Noneffectiveness of electroacupuncture for comorbid generalized anxiety disorder and irritable bowel syndrome. Journal of Gastroenterology and Hepatology. 34(10). 1736–1742. 12 indexed citations
8.
Jiang, Xinchan, Wai‐Kit Ming, & Joyce H. S. You. (2019). The Cost-Effectiveness of Digital Health Interventions on the Management of Cardiovascular Diseases: Systematic Review. Journal of Medical Internet Research. 21(6). e13166–e13166. 142 indexed citations
9.
Chumnumwat, Supatat, et al.. (2015). Cost-Effectiveness Of A Novel Pharmacist Guided Warfarin Pharmacogenetic Service. Value in Health. 18(7). A390–A390. 1 indexed citations
10.
Ip, Margaret, et al.. (2015). Characteristics and outcomes ofKlebsiella pneumoniaebacteraemia in Hong Kong. Infectious Diseases. 47(5). 283–288. 15 indexed citations
11.
Jiang, Minghuan & Joyce H. S. You. (2015). CYP2C19 genotype plus platelet reactivity-guided antiplatelet therapy in acute coronary syndrome patients. Pharmacogenetics and Genomics. 25(12). 609–617. 15 indexed citations
12.
Wong, Carlos King Ho, et al.. (2014). Prevention of gram-positive infections in peritoneal dialysis patients in Hong Kong: A cost-effectiveness analysis. American Journal of Infection Control. 42(4). 412–416. 12 indexed citations
13.
You, Joyce H. S., Wai‐Kit Ming, & Ping‐Lung Chan. (2014). Quadrivalent Influenza Vaccine in Hong Kong- a Cost-Effectiveness Analysis. Value in Health. 17(7). A678–A678. 1 indexed citations
14.
You, Joyce H. S.. (2013). Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis. Journal of General Internal Medicine. 29(3). 438–446. 46 indexed citations
15.
Wong, William Chi Wai, Eliza Lai‐Yi Wong, Han Li, et al.. (2012). Isoflavones in Treating Watchful Waiting Benign Prostate Hyperplasia: A Double-Blinded, Randomized Controlled Trial. The Journal of Alternative and Complementary Medicine. 18(1). 54–60. 22 indexed citations
17.
You, Joyce H. S., et al.. (2007). Linezolid versus Vancomycin for Prosthetic Joint Infections: a Cost Analysis. Infection. 35(4). 265–270. 8 indexed citations
19.
Woo, Kam-Sang, et al.. (2005). Assessing adherence to statin therapy using patient report, pill count, and an electronic monitoring device. American Journal of Health-System Pharmacy. 62(4). 411–415. 15 indexed citations
20.
You, Joyce H. S., et al.. (2001). Economic analysis of four triple regimens for the treatment of Helicobacter pylori‐related peptic ulcer disease in in‐patient and out‐patient settings in Hong Kong. Alimentary Pharmacology & Therapeutics. 15(7). 1009–1015. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026